TITLE

CLINICAL DATA/AVL AMICABLY TERMINATE DISTRIBUTORSHIP

PUB. DATE
August 2000
SOURCE
Worldwide Biotech;Aug2000, Vol. 12 Issue 8, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the termination of the distribution agreement between Clinical Data Pty. Ltd. and AVL Medical Instruments AG for the blood gas product line in Australia.
ACCESSION #
3449620

 

Related Articles

  • Financings Roundup.  // BioWorld Today;11/17/2010, Vol. 21 Issue 223, p5 

    The article reports on the shelf registration on Form S-3 to offer 200 million U.S. dollars in common stock, preferred stock and debt securities with terms to be determined at the time of the future offering filed by Clinical Data Inc. with the U.S. Securities and Exchange Commission.

  • Clinical Data announces public offering of common stock.  // PharmaWatch: CNS;Jul2010, Vol. 9 Issue 7, p27 

    The article reports on the plan of biotechnology company Clinical Data Inc. to offer all of its remaining shares of common stock in an underwritten public offering.

  • FINANCINGS ROUNDUP.  // BioWorld Today;6/15/2010, Vol. 21 Issue 114, p5 

    This section offers news briefs concerning the biotechnology industry, including Clinical Data Inc.'s public offering of 2,237,412 shares of common stock.

  • HRS Notebook.  // Medical Device Daily;5/13/2010, Vol. 14 Issue 92, p4 

    The article reports on the expansion of the Familion portfolio of genetic tests by Clinical Data's PGxHealth division.

  • Clinical Data files new drug application for depression drug.  // PharmaWatch: CNS;May2010, Vol. 9 Issue 5, p8 

    The article discusses the new drug application of Clinical Data Inc. for vilazodone for the treatment of major depressive disorder (MDD).

  • Clinical Data Raises $27.8M for Vilazodone.  // Bioworld Week;6/14/2010, Vol. 18 Issue 24, p5 

    The article reports on the 27.8 million-dollar fund raised by Newton, Massachusetts-based Clinical Data Inc. to commercialize its antidepressant vilazodone, the company's leading therapeutic candidate for depressive disorder treatment.

  • Schizophrenia linked with autoimmune disorders.  // PharmaWatch: CNS;May2007, Vol. 6 Issue 5, p10 

    The article reports on the publication of the result of the study demonstrating a novel association between a gene region associated with inflammation, autoimmune disorders and schizophrenia by Clinical Data Inc. The study compared genetic variants in individuals with schizophrenia to...

  • Clinical Data starts long-term safety study for Vilazodone.  // PharmaWatch: CNS;Feb2008, Vol. 7 Issue 2, p13 

    The article reports that Clinical Data Inc. has started new clinical trials for Vilazodone, a drug used for treatment of depression. The trial aims to evaluate the long-term safety and tolerability to Vilazodone. The company is confident it will help clinicians identify patients who are likely...

  • Clinical Data Lands Buyout, Forest Bets $1.2B on Viibryd.  // Bioworld Week;2/28/2011, Vol. 19 Issue 9, p1 

    The article reports on the buyout speculations for depression drug Viibryd from Clinical Data Inc. It mentions that New York-based Forest Laboratories Inc. is betting 1.2 billion U.S. dollars for the depression drug. It also notes that the buyout of the drug could help offset the declining sales...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics